Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

Success of approved gene therapies has resulted in a surge in interest of biopharmaceutical developers in this rapidly evolving domain. Presently, the ability of gene therapies to treat diverse disease indications is considered among the most prominent drivers of this market. In addition, promising clinical results of pipeline candidates are anticipated to draw in more investments to support product development initiatives.


To order this 720+ page report, which features 220+ figures and 375+ tables, please visit this https://www.rootsanalysis.com/reports/view_document/gene-therapies-market/268.html


The USD 14.6 billion (by 2030) financial opportunity within the gene therapy market has been analyzed across the following segments:

Therapeutic approach

  • Gene augmentation
  • Oncolytic therapy
  • Immunotherapy
  • Others

Type of gene therapy

  • Ex vivo
  • In vivo
  • Type of vector used
  • Adeno associated virus
  • Adenovirus
  • Herpes simplex virus
  • Lentivirus
  • Plasmid DNA
  • Retrovirus
  • Others

Key therapeutic areas

Autoimmune disorders

Cardiovascular diseases

Dermatological disorders

Genetic disorders

Hematological disorders

Metabolic disorders

Muscle-related diseases

Oncological disorders

Ophthalmic diseases


Route of administration

  • Intraarticular
  • Intracerebellar
  • Intradermal
  • Intramuscular
  • Intratumoral
  • Intravenous
  • Intravesical
  • Intravitreal
  • Subretinal
  • Others

Key geographical regions

North America


  • Asia-Pacific


The Gene Therapy Market (4th Edition), 2020-2030 report features the following companies, which we identified to be key players in this domain: 

  • Abeona Therapeutics
  • Advantagene
  • Biogen
  • bluebird bio
  • Castle Creek Biosciences
  • CG Oncology
  • FerGene
  • Freeline Therapeutics
  • Gradalis
  • Helixmith
  • Inovio Pharmaceuticals
  • Kolon TissueGene
  • Krystal Biotech
  • Lysogene
  • Neurophth Therapeutics
  • OncoSec Immunotherapies
  • Orchard Therapeutics
  • Pfizer
  • Sangamo Therapeutics
  • Spark Therapeutics
  • uniQure Biopharma

VBL Therapeutics


Table of Contents


1. Preface

2. Executive Summary

3. Introduction

4. Gene Delivery Vectors

5. Regulatory Landscape and Reimbursement Scenario

6. Market Overview

7. Competitive Landscape

8. Marketed Gene Therapies

9. Key Commercialization Strategies

10. Late Stage (Phase II/III and Above) Gene Therapies

11. Emerging Technologies

12. Key Therapeutics Areas

13. Patent Analysis

14. Mergers and Acquisitions

15. Funding and Investment Analysis

16. Clinical Trial Analysis

17. Cost Price Analysis

18. Big Pharma Players: Analysis of Gene Therapy Related Initiatives

19. Demand Analysis

20. Market Forecast and Opportunity Analysis


21. Vector Manufacturing


22. Case Study: Gene Therapy Supply Chain


23. Conclusion


24. Interview Transcripts


25. Appendix 1: Tabulated Data


26. Appendix 2: List of Companies and Organizations


To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/gene-therapies-market/268.html


Contact Details

Gaurav Chaudhary

+1 (415) 800 3415



Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe